Ulcerative Colitis Refractory to Anti-TNF

Daniel Stein; Salina Faidhalla

doi:10.1007/978-3-031-48949-5_31

Ulcerative Colitis Refractory to Anti-TNF

Daniel Stein^*, Salina Faidhalla

^*Corresponding author for this work

Medical College of Wisconsin

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

How effective are JAK inhibitors in a patient who has failed infliximab? What are the risks and benefits (including lack of immunogenicity) of JAK inhibitors, and how concerned should we be about MACE events and thrombosis? How beneficial are JAK inhibitors in treating acute severe UC in hospitalized patients?..

Original language	English
Title of host publication	Managing Complex Cases in Gastroenterology
Subtitle of host publication	a Curbside Guide
Publisher	Springer International Publishing
Pages	201-203
Number of pages	3
ISBN (Electronic)	9783031489495
ISBN (Print)	9783031489488
DOIs	https://doi.org/10.1007/978-3-031-48949-5_31
State	Published - 1 Jan 2023
Externally published	Yes

Access to Document

10.1007/978-3-031-48949-5_31

Cite this

@inbook{4610c66f6c1640f19edd4fd41ebe20e9,

title = "Ulcerative Colitis Refractory to Anti-TNF",

abstract = "How effective are JAK inhibitors in a patient who has failed infliximab? What are the risks and benefits (including lack of immunogenicity) of JAK inhibitors, and how concerned should we be about MACE events and thrombosis? How beneficial are JAK inhibitors in treating acute severe UC in hospitalized patients?..",

author = "Daniel Stein and Salina Faidhalla",

note = "Publisher Copyright: {\textcopyright} The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2023.",

year = "2023",

month = jan,

day = "1",

doi = "10.1007/978-3-031-48949-5\_31",

language = "אנגלית",

isbn = "9783031489488",

pages = "201--203",

booktitle = "Managing Complex Cases in Gastroenterology",

publisher = "Springer International Publishing",

address = "שוויץ",

}

TY - CHAP

T1 - Ulcerative Colitis Refractory to Anti-TNF

AU - Stein, Daniel

AU - Faidhalla, Salina

N1 - Publisher Copyright: © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2023.

PY - 2023/1/1

Y1 - 2023/1/1

N2 - How effective are JAK inhibitors in a patient who has failed infliximab? What are the risks and benefits (including lack of immunogenicity) of JAK inhibitors, and how concerned should we be about MACE events and thrombosis? How beneficial are JAK inhibitors in treating acute severe UC in hospitalized patients?..

AB - How effective are JAK inhibitors in a patient who has failed infliximab? What are the risks and benefits (including lack of immunogenicity) of JAK inhibitors, and how concerned should we be about MACE events and thrombosis? How beneficial are JAK inhibitors in treating acute severe UC in hospitalized patients?..

UR - http://www.scopus.com/inward/record.url?scp=85213551851&partnerID=8YFLogxK

U2 - 10.1007/978-3-031-48949-5_31

DO - 10.1007/978-3-031-48949-5_31

M3 - ???researchoutput.researchoutputtypes.contributiontobookanthology.chapter???

AN - SCOPUS:85213551851

SN - 9783031489488

SP - 201

EP - 203

BT - Managing Complex Cases in Gastroenterology

PB - Springer International Publishing

ER -

Ulcerative Colitis Refractory to Anti-TNF

Abstract

Access to Document

Other files and links

Fingerprint

Cite this